CLINICAL EVIDENCE THE EVRA STUDY
A randomized trial of early endovenous ablation in venous ulceration.1
Sign up to connect with us
EARLY ENDOVENOUS ABLATION TREATMENT MATTERS
In the EVRA study, venous leg ulcer patients treated with early endovenous ablation combined with compression therapy, when compared to delayed endovenous treatment, experienced1:
- Significantly shorter time to healing
- Extended time free from ulcers
EVRA STUDY FINDINGS
As published in the New England Journal of Medicine
32%
faster ulcer healing time in the early treatment group<sup>1</sup>
56 DAYS
median time to ulcer healing, compared to 82 in the control group<sup>1
28 DAYS
more ulcer-free time during the first year in the early treatment group<sup>1</sup>
The EVRA study was a multicenter, randomized clinical trial of 450 patients.
EXPERIENCE OUR CVI PORTFOLIO ADVANTAGE
Our comprehensive CVI toolkit empowers you to select the best approach for each patient.
Explore Products
VenaSeal™
Closure System
ClosureFast™
Radiofrequency Ablation System
Reference
1
Gohel MS, Heatley F, Liu X, et al. A Randomized Trial of Early Endovenous Ablation in Venous Ulceration. N Engl J Med. May 31, 2018;378(22)2105-2114.